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Abstract  
 
Chromosomal mutations lead to abnormal karyotypes and multiple genetic disorders in a variety 
of mammalian species. During extended cell culture and proliferation, human stem cells have 
demonstrated a predisposition to aneuploidy of chromosomes 12, 17, and X (Baker et al., 2007) 
and deletions or duplications of regions on Ch18  and Ch20 (Spits et al., 2008). Here we describe 
two additional chromosomal abnormalities (deletions on Ch10 and loss of heterozygosity on 
Ch5) associated with a female human embryonic stem cell H9 line that failed to undergo induced 
differentiation. Cytogenetic studies detected amplifications, deletions and translocations in 
multiple chromosomes. In an attempt to characterize these mutations, remapping, sequencing, 
and gene ontology was performed. Here we identify and analyze protein coding genes localizing 
to mutated regions.  
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1.0 Introduction  
 
Human embryonic stem cells (hESCs) have the ability to differentiate into all three germ layers 
promising novel approaches to clinical researches and genetic diseases hoping to develop a 
genetic system for human gene functions as well as come one step closer to personalized 
medicine (Abyeta et al., 2004). As promising and exciting as such approaches seem, working and 
maintaining stem cell lines is complex. hESCs that are used in most research are approved by the 
National Institute of Health (NIH) through a process that tests among others for contamination, 
gene expression during self-renewal and differentiation, ability to adapt in uniform cultures, 
growth efficiency, and karyotype stability (Ware, Nelson, Blau, 2006). There were only 22 NIH 
approved cell lines in August 2006; however there are 384 NIH approved cell lines in April 2017 
(NIH Human Embryonic Stem Cell Registry, 2017), meaning that in ten years the amount of 
research dedicated to the stem cells has massively increased, and so has the derivation of new 
cell lines. But, more cell lines means more chances of mutations and other random aberrations 
making the maintenance of in vitro stem cell lines challenging. Even though cell lines are tested 
for stability and uniformity in cell culture before NIH approval, extensive passages lead to 
mutations. Several studies have reported random acquisitions of chromosomal abnormalities in 
cells after prolonged culture (Baker et al., 2007) or cell dissociation technique during passaging 
methods (Tosca et. al., 2015). These karyotypically abnormal cells that exhibit increased growth 
are also found to be associated with reduced apoptosis and differentiation capacity leading to 
tumorigenesis in vivo (Baker et al., 2007). Hence, to support novel cell therapies and safe use of 
hESCs, research on characterizing common mutations among cell lines and identifying genes 
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that may be linked to their transformation, as well as research on optimal conditions of in vitro 
culture of hESCs are of special importance to the researchers wishing to advance cell therapy.  
This project summarizes and presents novel mutations of the WA09/H9 stem cell line cultured 
and passaged in vitro. Even though being one of the most popular stem cell lines, H9 line 
possesses a tendency to develop mutations even under expert handling and culturing (Ware, 
Nelson, and Blau, 2006). The objective was to characterize the karyotype of this cell line that 
failed to differentiate and to map key genes altered by chromosomal mutations. To achieve the 
goal, cytogenetic analysis was performed and bioinformatics approaches were used to remap, 
sequence and classify genes included in mutated regions based on their molecular function. 
Further, protein identification and interaction analysis were performed to investigate possible 
mechanistic consequences. The use of this cell line can provide more insight in the 
developmental biology field, as well as help in the advancement of drug discovery or 
transplantation medicine practices.  
Identifying and analyzing genes localized to mutated chromosomal regions of hESCs will 
contribute to the scientific knowledge of their role in cell transformation and will allow for the 
advancement of anti-cancer therapies.  
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2.0 Background  
 
2.1 WA09/H9 embryonic stem cell line  
H9 embryonic stem cell line is the most used and cited (more than 550 publications) in scientific 
research and is referred to as the “gold standard’ due to its stability (WiCell, 2012).  
H9 cells are pluripotent and are able to differentiate in to all three germ layers (mesoderm, 
endoderm and ectoderm). Several publications have documented the pluripotency of this cell 
line. This line was derived from a normal female embryo with a normal karyotype 46XX by 
Thomson Lab in Madison, Wisconsin (Thomson et. al., 1998). Distribution of the cell line is now 
managed by WiCell Research Institute, Madison, WI (International Stem Cell Registry, 2017). 
These human blastocyst-derived cells proliferated in vitro for four to five months and maintained 
the ability to form trophoblast and all the three embryonic layers, and were the first approved 
stem cell line (Thomson et. al., 1998).  
Prolonged cell culture of H9 cells drives selection of variant cells that cause genetic and 
epigenetic changes to the stem cell line that prevent their differentiation and do not drive 
apoptosis (Desmarais et. al., 2012), indicating their transformation.  
 
2.2 Commonly reported mutations   
Embryonic stem cell lines are prone to mutations under extensive culturing (Baker et. al., 2007). 
Common mutations have been characterized across different cell lines in chromosome 12, 17, 18, 
20 and X (Baker et. al., 2007; Spits et. al., 2008). Among the most common mutations is the 
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submicroscopic amplification of q arm in Ch20 that is considered a hot spot (Spits et. al., 2008). 
This genomic mutation was found consistent among several lines and 23 common genes were 
identified that were linked with oncogenic transformation (Lefort et. al., 2008). Gain of 
20q11.21-q11.22 region is a highly reported mutation among hESC lines (Avery et. al., 2013; 
Nguyen et al., 2013) linked with malignant transformation. Overexpression of BCL2L1 gene is 
identified to be a driver mutation due to growth advantage it provides to the cell (Avery et. al., 
2013). Other candidate genes for the mutated region of Ch20 were identified to be ID1 and 
HM13 (The International Stem Cell Initiative, 2011).  
 
2.3 Mutations on chromosome 5  
A few studies report a loss of heterozygosity on chromosome 5 (Ch 5) in human cells which has 
been related to several carcinomas. Studies conducted on somatic cells have observed that 5q 
loss of heterozygosity is linked with the FAP (familial polyposis coli) gene location and has been 
associated with colorectal cancers (Solomon et. al., 1987).  
Later studies in tumor cells (lung carcinoma) have identified several regions of chromosome 5q 
deletion or loss of heterozygosity for tumor suppressor genes in q11.2-q12.2, q22.3-q23.1, q31.1 
and q35.3 regions. Chromosome 5 is also a frequent target of genomic mutations in other cancers 
such as ovarian, gastric, or myeloid diseases (Mendes-da-Silva et. al., 2000).  
In patients with osteosarcoma, CHG analysis revealed several gains and losses, among which 
significant gains of chromosome 17 and loss of chromosome 5q were detected. Patients carrying 
a loss of 5q had a better prognosis. Data also indicated that the loss of 5q region may have an 
opposite effect to the overexpression of some oncogenes (Ozaki et. al., 2002). In malignant 
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glioma cell lines, cyclin B1 (CCNB1) and cyclin H (CCNH) have been identified as candidate 
genes due to exhibited increased growth and their location on 5q region (Weber et. al., 2000).  
 
2.4 Mutations on chromosome 10   
Mutations on chromosome 10p15.3 (duplication) have been associated with development delay 
and intellectual disability due to greater copy number variants (CNVs) and several candidate 
genes associated with such mutations and disorders (Cooper et. al., 2011).  
Chromosomal microarray assays (CMA) performed in individuals with deletions on the 10p15.3 
region identified two genes (ZMYND11 and DIP2C) that localize to the deleted region. The 
10p15.3 deletion was found to be mostly of a de novo nature and to be associated with several 
cognitive and development disorders such as speech delay, motor delay, brain anomalies and 
seizures (DeScipio et. al., 2012).  
Further studies depict ZMYND11 gene as a tumor suppressor gene responsible for transcription 
elongation of RNA polymerase II. This activity is specifically regulated through recognition of 
H3K36me3 (histone variant H3.3 lysine 36 trimethylation) by ZMYND11 on H3.3. Such 
recognition is critical in regulation of chromatin, hence ZMYND11 plays a key role in 
transcriptional repression. Reduced levels of ZMYND11 lead to worse prognosis in breast cancer 
patients; and increased levels of ZMYND11 lead to suppression of cancer cells in vitro (Wen et. 
al., 2014). The interplay between ZMYND11 and H3K36me3 has also been described in 
regulation of pre-mRNA processing, specifically splicing events (Guo et. al., 2014).  
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2.5 Mutations on chromosome 17   
17q amplification mutation have been reported on previous studies (Abel et al., 1999; Varis et 
al., 2002). GTP binding proteins located on chromosome 17 (q25 region) have been identified as 
candidate genes in cases of chromosome 17 mutations related to ovarian and breast tumors. 
These protein coding genes belong to the septin family and are involved in cytokinesis 
(McIlhatton et. al., 2001). The gains of 17q25.3 region have been identified through CGH 
analysis in human tumor cells and septin genes have been proposed as candidate gene. 
Specifically, Sept9 overexpression was shown to play a role in breast tumorigenesis through 
transfection with small interference RNA (Montagna et. al., 2003).  
In breast cancer studies, genomic alterations of chromosome regions in 17q have been reported 
(Shadeo & Wan, 2006). Amplifications of chromosome 17 regions reported by several studies 
usually corresponded with gains or mutation in other chromosomes. Since these gains are 
associated with neuroblastomas, in addition to breast cancer cases, BIRC5 located in 17q25 
region is suspected as a potential candidate gene (Baker et. al., 2007).  
Amplifications of 17q region and their relation with neuroblastomas has been established. For 
example, candidate genes were identified for 17q23 region, but not for the distal 17q region 
(Saito-Ohara et. al., 2003). Among other candidates on the amplified region of q arm of 
chromosome 17, FISH (fluorescence in situ hybridization) analysis revealed BIRC5 as a strong 
candidate gene in malignant peripheral nerve sheath tumor (Storlazzi et. al., 2006).   
 
2.6 Non-coding genes and miRNAs mutations  
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MicroRNAs (miRNAs) regulate gene expression at post-transcriptional level, hence being a 
target for treating neurological disorders (Sun, Liang & Pei, 2015). They are part of mRNA 
degradation process and responsible for inhibition of translation; they are linked with several 
biological processes such as cell proliferation, apoptosis, tumorigenesis and development. Micro 
RNAs were identified in chromosomes 7, 8, 11, and 17 and were associated with the mutations 
in these regions in breast cancer cell lines (Riaz et. al., 2013). Non-coding specific micro RNAs 
have been linked with corresponding mutated genes in thyroid carcinoma (Puppin et. al., 2014) 
and colon cancer (Nosho et. al., 2013), suggesting that miRNAs can be diagnostic biomarkers of 
cancer and key molecules in stem cell transformations.   
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3.0 Methods  
 
3.1 Embryonic Stem Cell Culture  
WA09/H9 stem cell line was obtained WiCell® and the WiCell Feeder Based (MEF) Pluripotent 
Stem Cell Protocol (SOP number: SOP-SH_001) was followed for maintaining this cell line in 
culture.  
hESCs were cultured on in-house, primary derived mouse embryonic fibroblasts (MEF) which 
was plated at a density of 2.25 x 104 cells/cm2 on plates that were coated for 60 minutes with 1% 
gelatin solution (MP Biologicals). MEF were inactivated with mitomycin-C (Sigma-Aldrich) for 
3 hours before plating (Kole et. al., 2017).   
Cells were grown in Stem Cell Culture Medium containing DMEM (Life Technologies), 15% 
Knockout serum (Life Technologies), 2 mM Glutamax (Life Technologies), 50 mM 2- 
mercaptoethanol (Sigma-Aldrich), 1× MEM non-essential amino acids (Mediatech) and 8 ng/mL 
FGF2 (Peprotech) (Kole et. al., 2017). After plating, cultures were incubated at 37 °C, 5% O2, 
5% CO2 and high humidity. hESCs were allowed to attach for a day and then daily feeding was 
performed through media replacement. Passaging procedures were performed after five days of 
growth. To dissociate the cells 0.01% trypsin (Mediatech) was used, then hESCs were split 1:12 
into new MEF feeder layers that were prepared as described above (Kole et. al., 2017).  
 
3.2 G-banded karyotyping  
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G-banded karyotyping is an optimized chromosome analysis for mouse and human pluripotent 
stem cells. A G-band karyotyping was used to asses and monitor the genomic stability of H9 
stem cell line after 28 passages. A karyotyping assay detects microscopic genomic abnormalities 
(5-10Mb) such as inversions, duplications, deletions, aneuploidies, and balanced and unbalanced 
translocations (Cytogenetic Services WiCell, 2012). To prepare the cells for G-banded 
karyotyping, cells in fixative were diluted and 20 well-spread metaphases were produced. During 
evaporation of the fixative, the surface of the slide becomes grainy and the cells become visible. 
The slide was facing a hot water bath (75°C) for up to three seconds and then was dried in a hot 
metal plate, whose temperature regulated chromosome spreading (Henegariu et. al., 2001). After 
overnight incubation at 65°C, G-banding assay was performed at 425-525 resolution.  
 
3.3 CGH+SNP microarray  
Comparative Genomic Hybridization (CGH) and Single Nucleotide Polymorphism (SNP) 
microarray was utilized (Agilent® dual color array with 60-mer oligonucleotide probes) to detect 
submicroscopic abnormalities smaller than 5Mb such as duplications, deletions, and unbalanced 
translocations. It can also distinguish loss of heterozygosity (LOH) and absence of 
heterozygosity (AOH), but it cannot detect balanced translocations or inversions, or the 
chromosomal positions of the genomic gains. When paired with a G-banded karyotype, it can 
define the translocation breakpoints (Cytogenetic Services WiCell, 2012). CGH utilizes in situ 
hybridization of metaphase spreads with two different genomic DNAs, one retrieved from the 
stem cell line (target) and one retrieved from a karyotypically normal reference. The two DNAs 
are labeled with different fluorochromes: green and red and are mixed 1:1 with excess of Cot 1 
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DNA (Bryndorf et. al., 1995). First, high-molecular-weight genomic DNA (both target and 
reference) was isolated from cell lysates and metaphase spreads were prepared. Before 
hybridization, target DNA was denatured and then mixed with the reference DNA, unlabeled Cot 
1 DNA. Metaphase spreads dry slides were hybridized at 37°C for 3 days (Bryndorf et. al., 
1995). Under the microscope, metaphase images were captured in two colors and ratios were 
determined. Regions that appear outside the -1 and +1 rate represented deletions and 
amplifications, respectively.  
 
3.4 Remapping  
NCBI Remap is an online tool used to project data from one coordinate system to another 
through the use of genomic alignments. A base-by-base analysis was performed to the source 
sequence (the sequence retrieved for this study) to present the same features in the new sequence 
(NCBI, 2017). NCBI offers three variations of Remap, but in this study only the Assembly-
Assembly remap feature was used to remap the features of hg19 assembly to the hg38 assembly. 
First, the organism of interest was selected, then the source assembly (the assembly the features 
are on) was chosen from the given list (hg19) and finally the target assembly (the assembly 
where the features will be projected) was selected (hg38). During remapping, the minimum ratio 
of bases was at default 0.5 meaning that at least 50% of the interval was able to be remapped. 
The maximum ratio for the difference between source and target length was at default 2 meaning 
that the algorithm allowed for insertions and deletions. This ratio was calculated as the ratio of 
interval lengths between target and source assembly.  
Maximum ratio = target assembly (stop-start +1)/ source assembly (stop-start +1)  
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An insertion or deletion in the target assembly would affect the ratio.  
Also, two other options of the NCBI Remap (the merge option and multiple location return 
option) were enabled to improve coordinate projections in case of duplications or large insertions 
in the sequence (NCBI, 2017).  
 
3.5 Gene Ontology and Gene Analytics online database  
Gene Ontology  
Gene Ontology (GO) emerged as a bioinformatics initiative to represent and annotate the gene 
functions at a molecular, cellular and tissue level. This computational approach describes gene 
products through a fixed vocabulary system which offers consistency genomic descriptions as 
well as serves as a tool to process data (Gene Ontology Consortium, 2017).  Gene ontology is 
species-independent ontology performed in three structural aspects regarding biological 
processes, cellular components and molecular functions. It includes the majority of genomes for 
plants, animals and microbial species. Despite the throughout analysis of genomes, Gene 
Ontology does not include several areas such as protein domains, protein-protein interactions, or 
environment, evolution and expression. It also does not contain specific terms such as 
oncogenesis to describe functions or components that are unique to mutants because cancer is not 
the normal function of a gene. However, an ontology offers insight on the relations between a set 
of terms in the perspective of a biological function, molecular function or cellular component. In 
a simple representation, a gene ontology can be given as a graph where each node represents a 
GO term and edges represent the relationship between nodes. In a GO graph the more general 
terms will be up and act as “parent” terms for the more specialized “child” terms that can be 
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found toward the bottom part of the graph (Gene Ontology Consortium, 2017). The three 
ontologies of GO are briefly explained below:  
 Cellular Component  
This ontology describes the component of a cell and location in a subcellular and 
macromolecular complex level. It includes protein complexes and multi-subunit enzymes, but 
not individual proteins (Gene Ontology Consortium, 2017).  
 Biological Process  
This ontology describes series of biological events/processes as a result of one or more of the 
assemblies of molecular functions, however they do not present a pathway. During the collection 
process there is a definite beginning and end for each biological process which can be either part 
of or an entire process of a parent node (Gene Ontology Consortium, 2017).  
 Molecular Function  
This ontology describes activities of usually individual genes at the molecular level such as 
binding or transporting activity. The function described by the ontology is unambiguous 
independent of species (Gene Ontology Consortium, 2017).  
GeneAnalytics  
GeneAnalytics is a gene set analysis tool provided by LifeMap Discovery®, a database for stem 
cell research supported by extensive molecular, cellular and medical data from scientific 
literature (LifeMap Discovery, 2017). Gene Analytics provides a GO analysis feature whose 
information is in integration with GeneCards, the human gene database. In addition to the three 
domains of GO, as described in the above section, GeneAnalytics provides additional 
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information on diseases and pathways, as well as simpler interpretation of results in regard to the 
provided gene set. The user-friendly features of this database make searching and data input and 
output easy to navigate.  
The data (gene set) was pasted on the search box and the organism of choice was selected (homo 
sapiens); in a few minutes a complete analysis with external links and explanations was 
available. Since a free trial was used during this study, not all of the features of the program were 
available. However, GeneAnalytics is a broad tool that provided information in several fields 
such as diseases, pathways, ontologies and phenotypes that were involved in the gene set of 
interest.  
3.6 Protein databases and resources  
Since the tools utilized so far in this study did not provide much information on the protein 
structure and interaction between the proteins retrieved from the protein coding genes, two more 
tools were utilized: Chimera USCF and STRING.  
UCSF Chimera  
UCSF Chimera is a modeling system used for interactive visualization and analysis of molecular 
structures. It is a free tool for download and it is associated with several tutorial videos to 
describe the functions and potentials of this tool. Several types of data can be processed in UCSF 
Chimera such as 3D density maps, light microscopy data, and protein or nucleic acid sequences 
and annotations (RBVI, 2016). In this study protein annotations were the primary data type used. 
The main goal of this software is to visually represent and analyze molecular assemblies, protein 
structure and function, binding interactions and protein network. Researchers use this program to 
annotate proteins of unknown function, identify targets for drug development as well as be able 
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to engineer and design new proteins (RBVI, 2016). In this study PDB annotations of proteins 
were used to retrieve a high quality image of the protein structure as well as to identify the 
binding domains and the protein interaction sites.  
First, Fetch structure by ID option was chosen from the File command on the top bar in order to 
insert a structural image of the desired protein. Through the Action command, colors, strands and 
other features of the protein were changed. Through the Tools command, selecting Structure 
Analysis and Surface/Binding Analysis provided more information on the binding sites of the 
selected protein. The final image was saved as a picture file. 
STRING  
STRING is an online database created by several research European institutions that provides 
known and predicted information on protein-protein interactions including physical and 
functional interactions. The five sources used by STRING database to retrieve this information 
are genomic predictions, high-throughput lab studies, co-expression data, automated text mining, 
and previous knowledge of databases. There are currently more than nine million proteins whose 
information is available on STRING (STRING, 2015). At the start page, the protein annotation 
and organism was selected. Different format for data input is available such as protein name or 
amino acid sequence. Then, a network view was shown which summarized basic information of 
the protein interactions in a user friendly way. Each node of the network contained detailed 
information on the respective protein. The confidence of each interaction was shown in a 
separate table under the Legend tab. Data setting tab allowed for change of the parameters such 
as the type of evidence used for the prediction. In this study, all five sources were used to 
retrieve data. The user can also choose the number of interactions that will be displayed, but a 
default of 10 best scoring hit interactions was chosen in this study.  
19 
 
There are many options available through the STRING website based on the analysis a 
researcher aims to perform. In this study basic features were used to give a representation of the 
network in which proteins interact with each other. 
.  
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4.0 Results  
Karyotyping and microarray tests provide the starting data, which are further analyzed through a 
series of online databases in order to spot individual candidate genes that may play a key role in 
the stem cell differentiation process. A karyotype containing random gained mutations was the 
starting point of this study. The karyotype represented the cell of a human embryonic stem cell 
line (WA09-H9-DL4) of a female line on its 28th passage. After these many passages the hESCs 
failed to differentiate, therefore a chromosome analysis report was utilized to reveal the genomic 
background of such non-differentiation. 20 metaphase chromosome spreads were examined. 
Below are presented the G-banded karyotyping results analysis and the CGH+SNP microarray 
results which depict the region of the mutation and the size of the mutation.  
4.1 G-banded karyotyping and CGH+SNP microarray  
Four different abnormalities were detected and presented below, where the first number shows 
the number of chromosomes (46), the sex (XX), type of abnormality, chromosome, and region of 
the chromosome:  
A) 46, XX, add(20)(q11.2)  
Five cells had an unbalanced 20q arm that shows gain (add for addition) of 20q11.21-q11.22 
region of approximately 4.2Mb  
B) 46, XX, der(10)t(10; 17)(p13; q11.2) 
Two cells had translocations (der for derivation) between short arm (p) of Ch10 and long arm (q) 
of Ch17 resulting in loss in 10p13-p15.3 region of 14.76 Mb and gain in 17q21.31-q25.3 region 
of 38.59 Mb.  
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C) 46, XX, der(10)t(10;17)(p13;q11.2), add(20)(q11.2) 
Eight cells displayed both of the abnormalities mentioned above, translocation between Ch10 
and Ch17 and amplification of Ch20.  
D) 46, XX, del(6)(p23), add(20)(q11.2)  
Three cells displayed deletion (del) of p23 region in Ch6 accompanied with the amplification of 
Ch20.  
Two cells out of 20 did not have any detectable mutations. The above presented results were 
supported by the CGH+SNP microarray, which reported another amplification in the 10p12.31-
p13 region of 6.06 Mb and a loss of heterozygosity greater than 3Mb in Ch5.  
A summary of the G-banded karyotyping assay is presented in Figure 1, below. 
 
Figure 1: Abnormal karyotype of WA09/H9 cell line of a human embryonic stem cell. The red arrows 
show two of the four aberrant clones: the loss in the short (p) arm of chromosome 10, and the unbalanced 
structural aberration gain in the long (q) arm of chromosome 20. 
22 
 
 
 
 
CGH+SNP microarray used to detect submicroscopic abnormalities presented all chromosomes 
in the dual color system as described in Section 3.3 and Figure 2 shows three of the 
chromosomes: Ch5, Ch10, Ch17.  
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Figure 2: CGH+SNP microarray result depicting the loss of heterozygosity on chromosome 5 at the 
region q14.3 as highlighted by the blue bar, the deletion on chromosome 10 at the region p15.3 and the 
amplification on chromosome 17 at the region q21.31.  
 
For a full view of the CGH+SNP microarray results refer to Appendix 1. All the mutations 
identified on each affected chromosome of H9 cell line sample are included in Table 1.  
Table 1: Chromosomes (Ch) with abnormalities and their specific region of mutation, size of the region 
in base pairs (bp), start and stop positions, and the type of mutation where AMP indicates amplification, 
DEL indicates deletion, and LOH indicates loss of heterozygosity. The data is presented in UCSC hg19 
reference system.  
Ch Region Size(bp) Start Stop Type 
1 q31.3 54582 196,744,721 196,799,302 AMP 
2 p11.2 115913 89,185,302 89,301,214 AMP 
4 p15.1 22133 34,787,128 34,809,260 DEL 
4 q13.2 90702 69,392,576 69,483,277 DEL 
5 q14.3 4463694 85,134,352 89,598,045 LOH 
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6 q14.1 44168 78,979,161 79,023,328 DEL 
7 q11.21 617325 62,073,606 62,690,930 AMP 
8 p11.22 122621 39,258,894 39,381,514 DEL 
10 p15.3 - p13 14760322 136,361 14,896,682 DEL 
10 p13 - p12.31 6064374 14,951,987 21,016,360 AMP 
10 q11.22 742031 46,949,255 47,691,285 DEL 
12 p13.31 76103 9,637,323 9,713,425 DEL 
14 q23.2 295009 63,502,514 63,797,522 AMP 
14 q23.3 398346 66,006,698 66,405,043 AMP 
14 q32.33 397605 106,405,703 106,803,307 AMP 
14 q32.33 362780 106,852,114 107,214,893 AMP 
16 p11.2 1628866 31,934,834 33,563,699 DEL 
17 q21.31 - q25.3 38592567 42,443,540 81,036,106 AMP 
20 q11.21 - q11.22 4206245 29,842,786 34,049,030 AMP 
X p22.33 2624974 60,701 2,685,674 AMP 
X q28 258241 154,974,667 155,232,907 AMP 
 
In addition to previously reported mutations, new or less common mutations were found in stem 
cells such as the deletion of 10p15.3 region or amplification of 10p12 region, as well as the loss 
of heterozygosity (LOH) in Ch5.  
Next we examined chromosome 5, 10 and 17 as the largest mutations observed in this stem cell 
line.  
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4.2 Remapping  
Since the results of the above tests are presented in hg19 assembly, an up to date presentation of 
data is retrieved through remapping into hg38 assembly. Below are presented the summary tables 
built from the information retrieved by NCBI Remap program.  
Chromosome 5  
 Source Mapped 
Id chr5 chr5 
Length 4463694 4463695 
Start 85134352 85838534 
Stop 89598045 90302228 
Strand + + 
Coverage 1 
 
Chromosome 10 
 Source Mapped 
Id chr10 chr10 
Length 147660322 14764263 
Start 136361 90421 
Stop 14896682 14854683 
Strand + + 
Coverage 1.00027 
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Chromosome 17  
 Source Mapped 
Id chr17 chr17 
Length 38592567 43083888 
Start 42443540 36449217 
Stop 81036106 79533104 
Strand + + 
Coverage 1.11638 
 
Since chr 17 had an amplified region a second pass was performed, hence the mapped region 
contained the duplication and had a greater length.  
 
4.3 Gene Mapping and Gene Ontology  
Using the new coordinates presented in the above section, a map of the mutated regions is 
retrieved together with the genes localized in these regions. Figures 3, 4 and 5 present the map of 
chromosome 5, 10 and 17, respectively.  
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Figure 3: 5q14.3 mutated region, the respective contig, genes and their symbols (names) and orientation 
strand (O) where the up arrow represents negative strand and the down arrow represents positive strand.  
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Figure 4: 10p15.3 mutated region, the respective contig, genes and their symbols (names) and orientation 
strand (O) where the up arrow represents negative strand and the down arrow represents positive strand.  
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Figure 5: 17q25.3 mutated region, the respective contig, genes and their symbols (names) and orientation 
strand (O) where the up arrow represents negative strand and the down arrow represents positive strand.  
 
GeneAnalytics database is used as the primary source to receive the ontology data due to its user 
friendly options. Genes of the mutated regions of chromosomes 5, 10 and 17 are classified based 
on biological process ontology, which describes the biological function under name column and 
indicates the number of the matched genes of the sample out of the total number of genes sharing 
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the same function. If clicked, the number will show the specific gene names, as indicated in the 
samples below. The full link for each chromosome presented can be found in Appendix 2.  
Chromosome 5  
 
 
Chromosome 10   
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Chromosome 17   
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4.4 Identification of cell proliferation-related genes  
Chromosome 5  
Candidate gene: CCNH (Cyclin H) – protein coding  
Location: q14.3  
GO Molecular Function: contributes to RNA polymerase II carboxy-terminal domain kinase 
activity  
The full map of the gene ontology analysis for this function can be found in Appendix 3.  
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CCNH gene, a protein-coding gene with PDB ID: 1KXU was fetched in the USCF Chimera and 
the protein structure was retrieved as can be seen on the left image. On the right image a 
predicted and known protein interaction map retrieved by the STRING database is presented.  
 
                                                  
Figure 6: An UCSF Chimera representation of the CCNH protein structure showing the alpha helices 
(green) and an interaction map between CCNH protein and other proteins.  
For more detailed data on specific interactions and the confidence score of each interaction, a 
link is provided in Appendix 2.  
Chromosome 10  
Candidate gene: ZMYND11 (Zinc Finger MYND-Type Containing 11) – protein coding  
Location: p15.3  
GO Molecular Function: RNA polymerase II regulatory region sequence-specific DNA binding  
The full map of the gene ontology analysis for this function can be found in Appendix 4.  
ZMYND11 gene, a protein-coding gene with PDB ID: 5HDA was fetched in the USCF Chimera 
and the protein structure was retrieved as can be seen on the left image. On the right image a 
predicted and known protein interaction map retrieved by the STRING database is presented.  
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Figure 7: An UCSF Chimera representation of the ZMYND11 protein structure showing the alpha 
helices (red) and beta sheets (purple) and an interaction map between ZMYND11 protein and other 
proteins.  
For more detailed data on specific interactions and the confidence score of each interaction, a 
link is provided in Appendix 2.  
Chromosome 17  
Candidate gene: BIRC5 (Baculoviral IAP Repeat Containing 5) – protein coding  
Location: q25.3 
GO Molecular Function: Ran GTPase binding – interacts with Ran, a GTP-binding protein 
involved in cell cycle progression, spindle assembly and nuclear organization assembly.  
The full map of the gene ontology analysis for this function can be found in Appendix 5.  
BIRC5 gene, a protein-coding gene with PDB ID: 3UEC was fetched in the USCF Chimera and 
the protein structure was retrieved as can be seen on the left image. On the right image a 
predicted and known protein interaction map retrieved by the STRING database is presented.  
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Figure 8: An UCSF Chimera representation of the BIRC5 protein structure showing the alpha helices 
(green) and beta sheets (blue) and an interaction map between BIRC5 protein and other proteins.  
For more detailed data on specific interactions and the confidence score of each interaction, a 
link is provided in Appendix 2.  
In the following section, an extensive analysis of each candidate gene supported by peer review 
literature is presented, as well as recommendations for future work. 
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5.0 Discussion  
In this section peer review literature discussed in Section 2.0 is used to interpret the findings of 
this study and further support the significance of the three identified genes as candidate genes 
that play a key role in stem cell in vitro culture.  
The three genes that are proposed in this study to be candidate genes are: CCNH, ZMYND11 
and BIRC5 gene in chromosomes 5, 10, and 17. On a larger picture, mutations in these 
chromosomes cause developmental and cognitive disabilities in vivo. 
Located on chromosome 5 (region q14.3), CCNH gene is a protein coding gene part of the RNA 
polymerase II kinase activity of the cell cycle process as revealed by the cytogenetic studies. Its 
direct interaction with CDK7 to form a complex as a CDK-activating kinase was confirmed by 
STRING analysis as presented in Figure 6 and the whole complex together with other CDKs and 
MAT1 protein is part of transcriptional regulation. Since this gene has lost heterozygosity as 
revealed by CGH analysis and is previously linked with tumor growth in glioma cells (Weber et. 
al., 2000), it is a strong candidate for the abnormalities of H9 stem cell line.  
Located on chromosome 10 (region p15.3), ZMYND11 gene is a protein coding gene part of the 
RNA polymerase II regulatory region sequence-specific DNA binding as revealed by cytogenetic 
studies. It acts as a transcriptional repressor by preventing tumor cell growth through its specific 
binding with histone H3 subtype (Wen et. al., 2014). STRING analysis revealed a direct 
interaction of ZMYND11 protein with DIP2C protein which has been previously mentioned in a 
2012 study (DeScipio et. al., 2012). Both these genes are deleted due to random mutation 
acquired during cell culture, therefore confirming their role as strong candidate genes for the 
abnormalities of H9 stem cell line. 10p15.3 deletions are linked with speech delay and language 
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disorders, motor delays and brain anomalies (DeScipio et al., 2012; Szalontai and Csiszar, 2013; 
Cobben et al., 2014).  
Located on chromosome 17 (region q25.3), BIRC5 gene is a protein coding gene part of the Ran 
GTPase binding as revealed by cytogenetic studies. This gene belongs to the IAP (inhibitor of 
apoptosis) family that negatively regulate cell death, meaning that higher expression of this gene 
can be found in tumors. Based on literature, GTPase binding proteins in 17q amplified regions 
have been linked to breast tumors (Montagna et. al., 2003). Its interaction with CASP9 as shown 
by the STRING analysis and other proteins forms a complex that promotes cell proliferation. 
Gains in 17q chromosome are related to early stage tumors of neuroblastoma (Abel et al., 1999; 
Krona et al., 2008). Since BIRC5 gene is amplified on chromosome 17, it is a strong candidate 
for the abnormalities of H9 stem cell line.  
Multiple cancers are associated with a combination of these mutations and others, indicating that 
the effects of random mutation of stem cells in vitro can have larger and fatal implications in 
vivo such as heart defects, growth delays, cognitive disorders and other severe conditions (Baker 
et al., 2007).  
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6.0 Future studies   
The genes proposed here as candidate genes in stem cell culture are protein coding genes, but the 
CGH analysis of the cell line revealed other non-coding sequences, mRNAs or microRNAs that 
were prone to mutations. Based on literature, microRNAs expression analysis can provide crucial 
information on the differentiation stages of the tumors and development processes (Lu et. al., 
2005). Hence, as a future recommendation, an extensive focus on these sequences, non-coding 
regions, microRNAs, and their interaction with protein coding genes is required to create a wide 
profile of candidate sequences that can contribute to the degeneration of stem cells into cancer 
cells.  
In this study, a bioinformatics and data analysis approach was taken to identify potential key 
genes. While this is the first and most important step in managing big and raw data, experimental 
approaches are required to verify the predictions and hypothesis stated in this paper. For the 
mentioned candidate genes, the next step would be to run transfection assays and record the 
changes through a second CGH analysis. Therefore, more data will be available to further 
support or oppose the role of the proposed genes. To investigate the functional relevance of these 
(and other) genes in transformation of the hESCs, expressing them in the cell through 
overexpression or knockdown will indicate the reaction of the cell toward differentiation. For 
example, since ZMYND11 gene is deleted from Ch10, overexpression can lead to phenotypical 
rescue. If the cells with the overexpressed ZMYND11 gene will be placed into neuronal 
differentiation environment and will be able to differentiate into neurons, it can be concluded 
that ZMYND11 indeed plays the key role in acquisition of transformed cell undifferentiated 
phenotype. Yet, there could be other factors that will need to be expressed in order to observe a 
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gain of function because as mentioned above about the role of microRNAs genes may colocalize 
with other expressed genes to carry their function.  
Lastly, considering the large number of cell lines used in research and their in vitro culturing, 
mutations may arise even through the differences in cell culture conditions (Tosca et. al., 2015), 
hence specific characterization of growing conditions is important for maintenance and 
improvement of cell line culture in vitro. In order to minimize random mutations acquired by 
genes in in vitro stem cell cultures, researchers should focus on the combined use of 
experimental and computational approaches in order to classify and identify these genomic 
abnormalities to assure safe use of hESCs.  
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8.0 Appendices  
 
Appendix 1 
 
Genomic view of the CGH+SNP microarray results. The upper picture indicates the deletion and 
amplification mutations, while the bottom picture indicates the loss of heterozygosity mutation. 
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Appendix 2  
 
GeneAnalytics Database  
Full analysis for chromosome 5 mutated region can be found at:  
https://ga.genecards.org/#results 
Full analysis for chromosome 10 mutated region can be found at: 
https://ga.genecards.org/#results  
Full analysis for chromosome 17 mutated region can be found at: 
https://ga.genecards.org/#results 
 
Note: To access these links it is required to have an account.  
 
 
STRING Database  
STRING analysis and detailed information on protein interaction for the candidate gene on 
chromosome 5 can be found at:                                                                                      
http://string-db.org/cgi/network.pl?taskId=i2JQBT92dij2  
 
STRING analysis and detailed information on protein interaction for the candidate gene on 
chromosome 10 can be found at:                                                                                     
http://string-db.org/cgi/network.pl?taskId=I7XLE0eNfrVw 
 
STRING analysis and detailed information on protein interaction for the candidate gene on 
chromosome 17 can be found at:                                                                                    
http://string-db.org/cgi/network.pl?taskId=kPfN1KTbnAYr  
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Appendix 3  
Graph view of the gene ontology molecular function of the candidate gene (CCNH) of 
chromosome 5 (GO: 0008353).  
 
Retrieved from: http://amigo.geneontology.org/amigo/term/GO:0008353 
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Appendix 4  
Graph view of the gene ontology molecular function of the candidate gene (ZMYND11) of 
chromosome 10 (GO: 0000977).  
 
 
Retrieved from: http://amigo.geneontology.org/amigo/term/GO:0000977 
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Appendix 5 
Graph view of the gene ontology molecular function of the candidate gene (BIRC5) of 
chromosome 17 (GO: 0008536).  
 
Retrieved from: http://amigo.geneontology.org/amigo/term/GO:0008536 
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